50% Gains Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henrik who wrote (27057)	9/27/2001 6:50:56 AM
From: Bocor	Read Replies (2) of 118717

FDA OKs Visible Genetics' HIV Genotyping System 26 Sep 19:07 NEW YORK -(Dow Jones)- Visible Genetics Inc. (VGIN) received approval from the U.S. Food and Drug Administration to market its Trugene HIV-1 Genotyping Kit and OpenGene DNA sequencing system. In a press release Wednesday, the company said this is the first HIV drug resistance test to receive clearance from the FDA. Toronto-based Visible Genetics submitted its Trugene HIV-1 Genotyping Kit and OpenGene system to the FDA on Sept. 5, 2000 as an "integrated system" comprised of the chemistry, hardware, software and interpretive patient report necessary to generate test results. The report provides information to the physician about which antiretroviral drugs are likely to be effective in treating the HIV infection of an individual patient, the company said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next